WeVote

Bill

Bill

S 3056

An Act relative to medication administration in rest homes

194th Legislature (2025-2026) Introduced by Pat Jehlen and 4 co-sponsors

Allows licensed rest homes to have designated staff (Responsible Persons) administer medications to non-self-administering residents under a new state regulatory framework.

Accompanied a new draft, see S3122
0
WeVote Research Nonpartisan
Bill Summary · S 3056

Summary of S.3056 (Session 194th) – An Act relative to medication administration in rest homes

Purpose and intent

  • Live in Massachusetts: The bill seeks to authorize and regulate the administration of medications to residents in rest homes (licensed under Chapter 111, §71) by designated staff.
  • Core goal: Allow rest homes to have Responsible Persons administer medications to residents who are not self-administering, under a regulatory framework established by the state.

Key provisions

  • Amendment to existing law: Section 7 of Chapter 94C of the General Laws (as appearing in the 2024 Official Edition) is amended to add a new subsection.
  • New regulatory framework (Subsection (k)):
    • The commissioner (presumably the Commissioner of Public Health) must promulgate regulations.
    • These regulations will establish a registration process for rest homes that are duly licensed under Chapter 111, §71.
    • The regulations will permit Responsible Persons employed by the rest home to administer medications to residents who are not self-administering.
  • No immediate operational provisions are included in the text provided beyond establishment of the regulatory authorization; specifics (training, supervision, scope of medications, documentation, and safety standards) would be anticipated in the forthcoming regulations.

Who is affected

  • Rest homes and long-term care facilities licensed under Chapter 111, §71.
  • Residents of these facilities who are not capable of self-administering medications.
  • Rest home staff designated as Responsible Persons who would be authorized to administer medications under the new regulatory framework.

Procedural and timeline aspects

  • Legislative path:
    • Referred to the Senate Committee on Rules (2/12/2026) and concurrently to the Joint Rules of the two branches.
    • Reported to the Senate with action history indicating passage by the Senate and concurrent committee actions.
    • House actions: Rules suspended (2/25/2026), then House concurred (4/15/2026), indicating the bill advanced through the legislative process toward enactment.
  • Regulatory timeline:
    • The bill directs the Commissioner to promulgate regulations establishing the registration process for rest homes and the framework for medication administration by Responsible Persons. The exact timeline for final regulations would be determined by the regulatory process following enactment.

Notable details

  • Sponsors: Lead sponsor Michael O. Moore; co-sponsors include Patricia D. Jehlen, Robyn K. Kennedy, John J. Marsi, Brian W. Murray, and others.
  • The bill text is concise, adding a new statutory subsection (k) to authorize regulation and registration for medication administration by rest-home staff to non-self-administering residents.

Potential impact and considerations

  • May improve medication management in rest homes by permitting trained staff to administer prescribed medications, potentially reducing delays and enhancing resident safety.
  • Regulatory oversight will be critical to ensure proper training, documentation, accountability, and safeguarding against medication errors.
  • Implementation will depend on the specifics of the forthcoming regulations (e.g., training requirements, supervision, incident reporting, scope of medications allowed, and pharmacy oversight).

If you’d like, I can provide a comparison with current practice in similar states or synthesize potential regulatory elements that are commonly included in medication administration programs for long-term care facilities.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.